{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:44:30Z","timestamp":1781919870616,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ejso.2015.01.005","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T00:45:15Z","timestamp":1421455515000},"page":"707-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA)"],"prefix":"10.1016","volume":"41","author":[{"given":"V.","family":"Milovanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ledakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sittig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2015.01.005_bib1","first-page":"1443","article-title":"Histopathological classification of pseudomyxoma peritonei and the prognostic importance of PINCH protein","volume":"32","author":"Andreasson","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2015.01.005_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/jclinpath-2012-200843","article-title":"Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases","volume":"65","author":"Carr","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.ejso.2015.01.005_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/modpathol.3880572","article-title":"Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations","volume":"15","author":"Kabbani","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2015.01.005_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000658-199401000-00009","article-title":"The natural history of surgically treated primary adenocarcinoma of the appendix","volume":"219","author":"Nitecki","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2015.01.005_bib5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1177\/000313481307901120","article-title":"Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival","volume":"79","author":"Shetty","year":"2013","journal-title":"Am Surg"},{"key":"10.1016\/j.ejso.2015.01.005_bib6","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","article-title":"Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \u201cpseudomyxoma peritonei\u201d","volume":"19","author":"Ronnett","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2015.01.005_bib7","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2015.01.005_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9","article-title":"Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy","volume":"92","author":"Elias","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2015.01.005_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","article-title":"Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy","volume":"6","author":"Sugarbaker","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.01.005_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2015.01.005_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jso.23547","article-title":"Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"109","author":"Blackham","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2015.01.005_bib12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cncr.24715","article-title":"Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience","volume":"116","author":"Shapiro","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2015.01.005_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00000658-199402000-00002","article-title":"Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach","volume":"219","author":"Gough","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2015.01.005_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/1097-0142(19920715)70:2<396::AID-CNCR2820700205>3.0.CO;2-A","article-title":"Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience","volume":"70","author":"Smith","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2015.01.005_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1245\/s10434-007-9691-2","article-title":"Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"15","author":"Baratti","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.01.005_bib16","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1245\/s10434-012-2789-1","article-title":"Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer","volume":"20","author":"Turner","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.01.005_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4240\/wjgs.v2.i8.265","article-title":"Peritoneal seeding from appendiceal carcinoma: a case report and review of the literature","volume":"2","author":"Bertuzzo","year":"2010","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.ejso.2015.01.005_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2407-13-67","article-title":"A\u00a0prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial","volume":"13","author":"Glockzin","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2015.01.005_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejso.2015.01.005_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1245\/s10434-011-1840-y","article-title":"The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS\/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis","volume":"19","author":"El","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.01.005_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1245\/s10434-011-1903-0","article-title":"Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer","volume":"19","author":"Halabi","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2015.01.005_bib22","doi-asserted-by":"crossref","first-page":"163284","DOI":"10.1155\/2012\/163284","article-title":"Systemic chemotherapy prior to cytoreductive surgery and HIPEC for carcinomatosis from appendix Cancer: impact on perioperative outcomes and short-term survival","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ejso.2015.01.005_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdr279","article-title":"Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix","volume":"23","author":"Lieu","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2015.01.005_bib24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.6004\/jnccn.2014.0109","article-title":"Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN oncology outcomes database for colorectal Cancer","volume":"12","author":"Tejani","year":"2014","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ejso.2015.01.005_bib25","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.3748\/wjg.14.5763","article-title":"Primary signet ring cell carcinoma of the appendix: a rare case report and our 18-year experience","volume":"14","author":"Ko","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2015.01.005_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000229245","article-title":"A\u00a0case of appendiceal adenocarcinoma with clinical benefit from FOLFOX and bevacizumab","volume":"2","author":"Powell","year":"2009","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.ejso.2015.01.005_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/gm559","article-title":"Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin","volume":"6","author":"Alakus","year":"2014","journal-title":"Genome Med"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T23:09:57Z","timestamp":1651014597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798315000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0748798315000116"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2015.01.005","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2015.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}